Option Care Stock Trades Below McKesson's Deal Price — Here's the Spread - Option Care Health (NASDAQ:OPC
Option Care Health (OPCH) agreed to be taken private by Clayton Dubilier & Rice and McKesson (MCK) for $32.05 per share, valuing the company at $5.8B. Shares traded at $31.05, leaving a $1.00 spread. The deal is expected to close in H1 2027, subject to approvals. McKesson will invest $1.4B for a 49% stake, with an option to buy out CD&R later. OPCH shares rose 32.78% on the news.
How this was made
The 30-second read
Why it matters
The deal creates a $1 per share arbitrage spread, translating to a 3.2% gross return, with an annualized 4.4% if the transaction closes at the end of the first half of 2027.
Market read
The announcement provides a fresh arbitrage opportunity in the healthcare sector, with a clear price target and defined timeline.
What to watch
Potential regulatory or state‑healthcare approvals could delay or derail the transaction, adding risk to the arbitrage play.
Background
Option Care Health, a home‑infusion provider, announced a take‑private deal with private‑equity firm Clayton Dubilier & Rice and distributor McKesson.
Ticker impact
Option Care Health agreed to be taken private at $32.05 per share, creating an arbitrage spread versus current market price.
likely upward pressure as arbitrage traders push the price toward $32.05, but limited upside due to thin spread and long timeline.
Deal is newly disclosed, sizable ($5.8 B), and the spread is explicitly quantified, giving traders a clear target.
McKesson is a co‑buyer in the $32.05 per share take‑private transaction for Option Care Health.
minimal direct impact; any movement will mirror the arbitrage dynamics of OPCH rather than McKesson’s own fundamentals.
While McKesson is a party, the market focus is on the target; the buyer’s stock typically sees limited reaction.
Market effects
The home‑infusion sector may see heightened M&A interest as consolidation accelerates.
U.S. healthcare M&A activity could receive a modest boost, but broader market impact is limited.
Limited to investors tracking U.S. healthcare deals and arbitrage strategies.
Counterpoint
The thin spread and long closing timeline may deter arbitrageurs, leading to a stagnant price rather than a rally.
Key entities
- CompanyOption Care Health
Target of the $32.05 per share buyout.
- Private EquityClayton Dubilier & Rice
Co‑buyer acquiring 51% of Option Care.
- CompanyMcKesson Corp.
Co‑buyer acquiring 49% of Option Care.
